OmniAb Inc. (OABI)

OmniAb Inc. (OABI) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $663M; returns 1 day -2.5%, 1 week +1.5%, 1 year +191.2%.

OmniAb, Inc. is a biotechnology company that licenses its discovery research technology to pharmaceutical, biotech companies, and academic institutions for the discovery of therapeutics. Its technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts.

Groups OABI belongs to

• Biotechnology
• Antibody Therapeutics
• Drug Discovery
• Life Sciences Tools & Services
• Royalty Streams
• Biopharmaceutical
• Healthcare Technology
• Monoclonal Antibodies
• Commercial Stage Biotech
• Life Sciences

OABI financial model: income statement, cash flow and balance sheet